Replay available

Ryman Healthcare Limited (RHCGF) Q4 2026 Earnings Call

Ryman Healthcare Limited (OTC: RHCGF) Q4 2026 earnings conference call, held 2026-05-25. Replay captured from the company's public earnings webcast.

Mon, May 25, 2026 at 7:00 PMendedReplay
Ryman Healthcare Limited (RHCGF) Q4 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Naomi James

Chief Executive Officer

Matt Pryor

Chief Financial Officer

Hayden Strickett

Head of Investor Relations

Ari Becker

Analyst, Jarden

Will Twiss

Analyst, Forsofar

Stephen Ridgewell

Analyst, Craigs Investment Partners

Bianca Murphy

Analyst, UDS

Nick Marr

Analyst, Macquarie

Replay transcript excerpt

Thank you for standing by and welcome to the Ryman Healthcare full-year results briefing. All participants are in a listen-only mode. There will be a presentation followed by a question at the end of the session. If you would like to ask a question, you'll need to press the star key followed by the number one on your telephone keypad. I'll now like to hand the conference over to Naomi James, Chief Executive Officer. Please go ahead. Welcome everyone and thank you for joining us for our FY26 full-year results. With me today, I have Matt Pryor, our CFO, and Hayden Strickett, our Head of Investor Relations. Today, we will run through the significant progress we've made and how this is translating into improved performance. Reflecting our strategy refresh, we will talk to retirement living and then to aged care, showing the differences of these earnings streams. And we'll leave time at the end for your questions. Let's start with the highlights on slide four. FY26 marks an important operational inflection point for Ryman, with the work undertaken over the last two years now translating into improved performance, cash flow generation and balance sheet strength. Earnings momentum is building. With growth in recurring earnings and significant costs removed, we've doubled our operating EBITDAF. And for the first time in more than a decade, we delivered positive free cash flow of $188 million. This has been delivered in mixed market conditions, demonstrating the resilience and sustainability of the actions taken. We now have a strong and flexible balance sheet with the completion of our bank refinancing during the year. This, alongside our new capital management framework and $147 million in contracted land investments, provides Ryman with much greater resilience and flexibil...

More from Ryman Healthcare Ltd.